Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus

ABSTRACT Objective: To evaluate the prevalence of osteosarcopenia and the association of osteosarcopenia with trabecular bone score (TBS) in a group of patients with type 2 diabetes mellitus(T2DMG) compared with a paired control group (CG). Materials and methods: Cross-sectional study with men and women ≥ 50 years recruited by convenience. Patients in both groups answered questionnaires and underwent evaluation of bone mineral density (BMD), handgrip strength (HGS), and TBS. The T2DMG also underwent a gait speed (GS) test. Sarcopenia was defined as low lean mass plus low HGS or GS according to the Foundation for the National Institute of Health Sarcopenia Project, and osteosarcopenia was deemed present when sarcopenia was associated with osteopenia, osteoporosis, or low-energy trauma fractures. Results: The T2DMG (n = 177) and CG (n = 146) had, respectively, mean ages of 65.1 ± 8.2 years and 68.8 ± 11.0 years and 114 (64.4%) and 80 (54.7%) women. T2DMG versus the CG had higher rates of osteosarcopenia (11.9% versus 2.14%, respectively, p = 0.010), sarcopenia (12.9% versus 5.4%, respectively, p < 0.030), and fractures (29.9% versus 18.5%, respectively, p = 0.019), and lower HGS values (24.4 ± 10.3 kg versus 30.9 ± 9.15 kg, respectively, p < 0.001), but comparable BMD values. Mean TBS values were 1.272 ± 0.11 and 1.320 ± 0.12, respectively (p = 0.001). On multivariate analysis, age, greater waist circumference, fractures, and osteoporosis increased the risk of degraded TBS. Osteosarcopenia was associated with diabetes complications (p = 0.03), calcium and vitamin D supplementation (p = 0.01), and all components of osteosarcopenia diagnosis (p < 0.05). Conclusion: Compared with the CG, the T2DMG had a higher prevalence of osteosarcopenia, sarcopenia, and fractures and lower bone quality assessed by TBS.

Saved in:
Bibliographic Details
Main Authors: Pechmann,Luciana Muniz, Petterle,Ricardo R., Moreira,Carolina A., Borba,Victoria Z. C.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600801
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-39972021000600801
record_format ojs
spelling oai:scielo:S2359-399720210006008012021-12-03Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitusPechmann,Luciana MunizPetterle,Ricardo R.Moreira,Carolina A.Borba,Victoria Z. C. Sarcopenia type 2 diabetes mellitus muscle weakness fractures osteoporosis ABSTRACT Objective: To evaluate the prevalence of osteosarcopenia and the association of osteosarcopenia with trabecular bone score (TBS) in a group of patients with type 2 diabetes mellitus(T2DMG) compared with a paired control group (CG). Materials and methods: Cross-sectional study with men and women ≥ 50 years recruited by convenience. Patients in both groups answered questionnaires and underwent evaluation of bone mineral density (BMD), handgrip strength (HGS), and TBS. The T2DMG also underwent a gait speed (GS) test. Sarcopenia was defined as low lean mass plus low HGS or GS according to the Foundation for the National Institute of Health Sarcopenia Project, and osteosarcopenia was deemed present when sarcopenia was associated with osteopenia, osteoporosis, or low-energy trauma fractures. Results: The T2DMG (n = 177) and CG (n = 146) had, respectively, mean ages of 65.1 ± 8.2 years and 68.8 ± 11.0 years and 114 (64.4%) and 80 (54.7%) women. T2DMG versus the CG had higher rates of osteosarcopenia (11.9% versus 2.14%, respectively, p = 0.010), sarcopenia (12.9% versus 5.4%, respectively, p < 0.030), and fractures (29.9% versus 18.5%, respectively, p = 0.019), and lower HGS values (24.4 ± 10.3 kg versus 30.9 ± 9.15 kg, respectively, p < 0.001), but comparable BMD values. Mean TBS values were 1.272 ± 0.11 and 1.320 ± 0.12, respectively (p = 0.001). On multivariate analysis, age, greater waist circumference, fractures, and osteoporosis increased the risk of degraded TBS. Osteosarcopenia was associated with diabetes complications (p = 0.03), calcium and vitamin D supplementation (p = 0.01), and all components of osteosarcopenia diagnosis (p < 0.05). Conclusion: Compared with the CG, the T2DMG had a higher prevalence of osteosarcopenia, sarcopenia, and fractures and lower bone quality assessed by TBS.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.65 n.6 20212021-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600801en10.20945/2359-3997000000418
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pechmann,Luciana Muniz
Petterle,Ricardo R.
Moreira,Carolina A.
Borba,Victoria Z. C.
spellingShingle Pechmann,Luciana Muniz
Petterle,Ricardo R.
Moreira,Carolina A.
Borba,Victoria Z. C.
Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
author_facet Pechmann,Luciana Muniz
Petterle,Ricardo R.
Moreira,Carolina A.
Borba,Victoria Z. C.
author_sort Pechmann,Luciana Muniz
title Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_short Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_full Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_fullStr Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_full_unstemmed Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_sort osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
description ABSTRACT Objective: To evaluate the prevalence of osteosarcopenia and the association of osteosarcopenia with trabecular bone score (TBS) in a group of patients with type 2 diabetes mellitus(T2DMG) compared with a paired control group (CG). Materials and methods: Cross-sectional study with men and women ≥ 50 years recruited by convenience. Patients in both groups answered questionnaires and underwent evaluation of bone mineral density (BMD), handgrip strength (HGS), and TBS. The T2DMG also underwent a gait speed (GS) test. Sarcopenia was defined as low lean mass plus low HGS or GS according to the Foundation for the National Institute of Health Sarcopenia Project, and osteosarcopenia was deemed present when sarcopenia was associated with osteopenia, osteoporosis, or low-energy trauma fractures. Results: The T2DMG (n = 177) and CG (n = 146) had, respectively, mean ages of 65.1 ± 8.2 years and 68.8 ± 11.0 years and 114 (64.4%) and 80 (54.7%) women. T2DMG versus the CG had higher rates of osteosarcopenia (11.9% versus 2.14%, respectively, p = 0.010), sarcopenia (12.9% versus 5.4%, respectively, p < 0.030), and fractures (29.9% versus 18.5%, respectively, p = 0.019), and lower HGS values (24.4 ± 10.3 kg versus 30.9 ± 9.15 kg, respectively, p < 0.001), but comparable BMD values. Mean TBS values were 1.272 ± 0.11 and 1.320 ± 0.12, respectively (p = 0.001). On multivariate analysis, age, greater waist circumference, fractures, and osteoporosis increased the risk of degraded TBS. Osteosarcopenia was associated with diabetes complications (p = 0.03), calcium and vitamin D supplementation (p = 0.01), and all components of osteosarcopenia diagnosis (p < 0.05). Conclusion: Compared with the CG, the T2DMG had a higher prevalence of osteosarcopenia, sarcopenia, and fractures and lower bone quality assessed by TBS.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600801
work_keys_str_mv AT pechmannlucianamuniz osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus
AT petterlericardor osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus
AT moreiracarolinaa osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus
AT borbavictoriazc osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus
_version_ 1756441476194107392